Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, has released a new edition of its “State of Rural Hospitals and Cardiovascular Care” report. The report is designed to assist rural healthcare leaders, policymakers, and community-based organizations in improving cardiovascular care quality and outcomes in rural areas, where disparities in access and health outcomes remain pronounced.
The updated report identifies key challenges facing rural cardiovascular care, including shortages of specialists and physicians, limited broadband access, and a higher prevalence of cardiovascular disease risk factors among rural populations. These factors contribute to a higher burden of disease and worse outcomes compared to urban counterparts. The report also underscores the need for innovative solutions that can bridge these gaps.
To address these issues, Cardio Diagnostics proposes a four-part care model that emphasizes upskilling primary care clinicians, advancing care through epigenetic-genetic testing, implementing population-wide health strategies, and integrating remote care options in rural communities. This model aims to leverage existing healthcare infrastructure while introducing new technologies to enhance early detection, access, and personalized care.
The report highlights the role of technologies such as virtual cardiac care and precision-medicine testing in transforming rural cardiovascular care. Virtual cardiac care can help overcome specialist shortages by enabling remote consultations and monitoring, while precision-medicine testing, like Cardio Diagnostics’ own AI-driven tests, can provide personalized risk assessments and guide treatment decisions without requiring extensive local laboratory infrastructure.
“The revised report addresses the role of technologies including virtual cardiac care and precision-medicine testing in strengthening early detection, access, and personalized care,” the company stated. By focusing on these areas, the report aims to provide actionable strategies for rural healthcare stakeholders.
The release of this report comes at a time when cardiovascular disease remains the leading cause of death in the United States, and rural communities are disproportionately affected. According to the Centers for Disease Control and Prevention, rates of heart disease and stroke are higher in rural areas, partly due to factors such as poverty, lack of health insurance, and limited access to healthcare services. The report’s emphasis on practical solutions is timely and could influence policy and investment decisions.
Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The company was formed to further develop and commercialize clinical tests by leveraging a proprietary AI-driven Integrated Genetic-Epigenetic Engine for cardiovascular disease. Its mission is to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease.
For more information about the report, visit the full press release at https://ibn.fm/H28lM. For the latest news and updates on Cardio Diagnostics, see the company’s newsroom at https://ibn.fm/CDIO.
